Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
MassMutual Equity Opportunities Fund
mutual fund
MFVAX
Payout Change
Pending
Price as of:
$16.79
-0.04
-0.24%
primary theme
U.S. Large-Cap Blend Equity
MFVAX (Mutual Fund)
MassMutual Equity Opportunities Fund
Payout Change
Pending
Price as of:
$16.79
-0.04
-0.24%
primary theme
U.S. Large-Cap Blend Equity
MFVAX (Mutual Fund)
MassMutual Equity Opportunities Fund
Payout Change
Pending
Price as of:
$16.79
-0.04
-0.24%
primary theme
U.S. Large-Cap Blend Equity
Name
As of 12/11/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
12.5%
1 yr return
14.3%
3 Yr Avg Return
6.4%
5 Yr Avg Return
9.8%
Net Assets
$647 M
Holdings in Top 10
33.4%
52 WEEK LOW AND HIGH
$16.8
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 1.25%
SALES FEES
Front Load 5.50%
Deferred Load N/A
TRADING FEES
Turnover 25.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 12/11/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
MFVAX - Profile
Distributions
- YTD Total Return 12.5%
- 3 Yr Annualized Total Return 6.4%
- 5 Yr Annualized Total Return 9.8%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 0.70%
- Dividend Yield 0.8%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameMassMutual Equity Opportunities Fund
-
Fund Family NameMASSMUTUAL FUNDS
-
Inception DateOct 08, 2001
-
Shares OutstandingN/A
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerDonald Kilbride
Fund Description
Principal Investment Strategies
The Fund invests primarily in equity securities of U.S. companies that the Fund’s subadvisers believe are financially sound, valued conservatively by the market, and have improving prospects. The Fund is managed by two subadvisers, T. Rowe Price Associates, Inc. (“T. Rowe Price”) and Wellington Management Company LLP (“Wellington Management”), each being responsible for a portion of the portfolio, although they may manage different amounts of the Fund’s assets. Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities. Equity securities may include common stocks, preferred stocks, securities convertible into common or preferred stocks, rights, and warrants, of issuers of any size. The Fund typically invests most of its assets in equity securities of U.S. companies, but may invest in foreign securities and American Depositary Receipts (“ADRs”), including emerging market securities. The Fund generally will not invest more than 30% of its total assets in foreign securities. The Fund may use futures contracts for hedging or investment purposes as a substitute for investing directly in securities. Use of derivatives by the Fund may create investment leverage. The Fund may at times have significant exposure to one or more industries or sectors. The Fund may hold a portion of its assets in cash or cash equivalents.
T. Rowe Price typically employs a “value” approach in selecting investments, using internal research to identify companies that appear to be undervalued by various measures and may be temporarily out of favor but have good prospects
for capital appreciation and dividend growth. T. Rowe Price generally looks for companies with one or more of the following: an established operating history; above-average dividend yield and low price/earnings ratio relative to the Russell 1000® Value Index; a sound balance sheet and other positive financial characteristics; and low stock price relative to T. Rowe Price’s view of the company’s underlying value as measured by assets, cash flow, or business franchises. T. Rowe Price generally seeks investments in large-capitalization companies and the yield of the portion of the Fund managed by T. Rowe Price is expected to normally exceed the yield of the Russell 1000 Value Index. T. Rowe Price may sell assets for a variety of reasons, including in response to a change in the original investment considerations or to limit losses, adjust the characteristics of the overall portfolio, or redeploy assets into different opportunities.
Wellington Management seeks long-term total returns in excess of the broad market by investing in a select number of high quality, reasonably-valued companies that have demonstrated the willingness to return value to shareholders. The investment process stresses security selection based on bottom-up fundamental research to identify attractively valued stocks that have the potential for significant longer-term rewards. Wellington Management’s investment philosophy is based on the premise that investing in high quality companies with superior prospects for dividend growth, and the fundamental strength to support that growth in the future, can provide superior long-term returns. Wellington Management typically sells a security when it achieves its price target or when it no longer exhibits superior upside return versus downside risk.
In pursuing the Fund’s investment objective, each of T. Rowe Price and Wellington Management has the discretion to purchase some securities that do not meet its normal investment criteria described above, when it believes there is an opportunity for substantial appreciation (such as, for example, T. Rowe Price or Wellington Management believes a security could increase in value as a result of a change in management, an extraordinary corporate event, a new product introduction or innovation, or a favorable competitive development).
MFVAX - Performance
Return Ranking - Trailing
| Period | MFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 12.5% | 4.3% | 46.2% | 97.69% |
| 1 Yr | 14.3% | 5.8% | 61.3% | 98.60% |
| 3 Yr | 6.4%* | -11.0% | 19.2% | 83.00% |
| 5 Yr | 9.8%* | -7.6% | 110.6% | 92.15% |
| 10 Yr | 10.2%* | -0.1% | 52.9% | 85.87% |
* Annualized
Return Ranking - Calendar
| Period | MFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 5.2% | -42.6% | 47.4% | 93.47% |
| 2022 | -19.6% | -56.3% | -4.2% | 31.56% |
| 2021 | 8.1% | -27.2% | 537.8% | 83.84% |
| 2020 | 1.2% | -22.5% | 2181.7% | 91.66% |
| 2019 | 17.3% | -13.5% | 40.4% | 79.91% |
Total Return Ranking - Trailing
| Period | MFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 12.5% | 4.3% | 46.2% | 97.69% |
| 1 Yr | 14.3% | 5.8% | 61.3% | 98.60% |
| 3 Yr | 6.4%* | -11.0% | 19.2% | 83.00% |
| 5 Yr | 9.8%* | -7.6% | 110.6% | 92.15% |
| 10 Yr | 10.2%* | -0.1% | 52.9% | 85.87% |
* Annualized
Total Return Ranking - Calendar
| Period | MFVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 10.2% | -5.0% | 47.4% | 96.03% |
| 2022 | -5.0% | -36.8% | -2.2% | 1.83% |
| 2021 | 22.7% | 3.0% | 537.8% | 87.06% |
| 2020 | 8.8% | -15.8% | 2266.0% | 91.66% |
| 2019 | 28.6% | -0.4% | 241.3% | 64.33% |
NAV & Total Return History
MFVAX - Holdings
Concentration Analysis
| MFVAX | Category Low | Category High | MFVAX % Rank | |
|---|---|---|---|---|
| Net Assets | 647 M | 2.34 M | 1.55 T | 61.91% |
| Number of Holdings | 69 | 2 | 3963 | 65.70% |
| Net Assets in Top 10 | 217 M | 880 K | 525 B | 66.20% |
| Weighting of Top 10 | 33.41% | 0.3% | 111.6% | 65.23% |
Top 10 Holdings
- COMMON STOCK USD.00000625 3.82%
- COMMON STOCK USD.01 3.66%
- COMMON STOCK USD.01 3.51%
- COMMON STOCK 3.47%
- COMMON STOCK USD.0000225 3.33%
- COMMON STOCK USD.00001 3.20%
- COMMON STOCK USD1.0 3.20%
- COMMON STOCK 3.13%
- COMMON STOCK 3.12%
- COMMON STOCK USD1.0 2.98%
Asset Allocation
| Weighting | Return Low | Return High | MFVAX % Rank | |
|---|---|---|---|---|
| Stocks | 98.23% | 0.00% | 105.79% | 67.60% |
| Other | 1.03% | -13.91% | 100.00% | 8.00% |
| Cash | 0.41% | 0.00% | 99.07% | 67.19% |
| Preferred Stocks | 0.33% | 0.00% | 2.03% | 0.74% |
| Convertible Bonds | 0.13% | 0.00% | 5.54% | 2.15% |
| Bonds | 0.00% | 0.00% | 93.85% | 36.85% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | MFVAX % Rank | |
|---|---|---|---|---|
| Healthcare | 20.93% | 0.00% | 52.29% | 5.46% |
| Financial Services | 19.28% | 0.00% | 55.59% | 9.82% |
| Industrials | 14.56% | 0.00% | 29.90% | 7.14% |
| Consumer Defense | 14.09% | 0.00% | 47.71% | 3.86% |
| Consumer Cyclical | 10.65% | 0.00% | 30.33% | 51.64% |
| Basic Materials | 6.60% | 0.00% | 25.70% | 6.30% |
| Technology | 5.88% | 0.00% | 48.94% | 97.65% |
| Utilities | 2.87% | 0.00% | 20.91% | 37.28% |
| Real Estate | 2.29% | 0.00% | 31.91% | 63.22% |
| Energy | 1.75% | 0.00% | 41.64% | 79.26% |
| Communication Services | 1.10% | 0.00% | 27.94% | 97.06% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | MFVAX % Rank | |
|---|---|---|---|---|
| US | 96.79% | 0.00% | 105.79% | 73.21% |
| Non US | 1.44% | 0.00% | 63.83% | 14.84% |
MFVAX - Expenses
Operational Fees
| MFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.25% | 0.01% | 19.75% | 22.49% |
| Management Fee | 0.69% | 0.00% | 1.90% | 79.87% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 39.26% |
| Administrative Fee | 0.30% | 0.00% | 0.85% | 92.05% |
Sales Fees
| MFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 5.50% | 1.00% | 5.75% | 53.96% |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| MFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 0.25% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| MFVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 25.00% | 0.00% | 268.00% | 52.35% |
MFVAX - Distributions
Dividend Yield Analysis
| MFVAX | Category Low | Category High | MFVAX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.84% | 0.00% | 25.47% | 65.62% |
Dividend Distribution Analysis
| MFVAX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annual | Quarterly | Annual |
Net Income Ratio Analysis
| MFVAX | Category Low | Category High | MFVAX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.70% | -54.00% | 2.44% | 49.87% |
Capital Gain Distribution Analysis
| MFVAX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Semi-Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 13, 2023 | $0.140 | OrdinaryDividend |
| Dec 13, 2023 | $0.563 | CapitalGainLongTerm |
| Dec 14, 2022 | $2.638 | OrdinaryDividend |
| Dec 16, 2021 | $0.137 | OrdinaryDividend |
| Dec 16, 2021 | $0.119 | CapitalGainShortTerm |
| Dec 16, 2021 | $2.080 | CapitalGainLongTerm |
| Dec 14, 2020 | $0.148 | OrdinaryDividend |
| Dec 14, 2020 | $0.102 | CapitalGainShortTerm |
| Dec 14, 2020 | $0.942 | CapitalGainLongTerm |
| Dec 16, 2019 | $0.191 | OrdinaryDividend |
| Dec 16, 2019 | $0.022 | CapitalGainShortTerm |
| Dec 16, 2019 | $1.328 | CapitalGainLongTerm |
| Dec 17, 2018 | $0.354 | CapitalGainShortTerm |
| Dec 17, 2018 | $1.077 | CapitalGainLongTerm |
| Dec 17, 2018 | $0.170 | OrdinaryDividend |
| Dec 15, 2017 | $2.052 | CapitalGainShortTerm |
| Dec 15, 2017 | $4.499 | CapitalGainLongTerm |
| Dec 15, 2017 | $0.363 | OrdinaryDividend |
| Dec 15, 2016 | $0.142 | CapitalGainShortTerm |
| Dec 15, 2016 | $0.217 | CapitalGainLongTerm |
| Dec 15, 2016 | $0.144 | OrdinaryDividend |
| Dec 15, 2015 | $0.075 | CapitalGainShortTerm |
| Dec 15, 2015 | $2.859 | CapitalGainLongTerm |
| Dec 15, 2015 | $0.242 | OrdinaryDividend |
| Aug 28, 2015 | $0.251 | CapitalGainLongTerm |
| Dec 15, 2014 | $2.521 | CapitalGainLongTerm |
| Dec 15, 2014 | $0.333 | OrdinaryDividend |
| Dec 16, 2013 | $0.332 | CapitalGainShortTerm |
| Dec 16, 2013 | $1.818 | CapitalGainLongTerm |
| Dec 16, 2013 | $0.013 | OrdinaryDividend |
| Dec 17, 2012 | $0.350 | CapitalGainShortTerm |
| Dec 17, 2012 | $0.953 | CapitalGainLongTerm |
| Dec 17, 2012 | $0.071 | OrdinaryDividend |
| Dec 15, 2011 | $0.317 | CapitalGainLongTerm |
| Dec 15, 2011 | $0.040 | OrdinaryDividend |
| Aug 25, 2010 | $0.050 | ExtraDividend |
| Dec 18, 2008 | $0.122 | OrdinaryDividend |
| Aug 25, 2008 | $0.552 | CapitalGainLongTerm |
| Dec 14, 2007 | $0.029 | OrdinaryDividend |
| Dec 04, 2007 | $0.575 | CapitalGainShortTerm |
| Dec 04, 2007 | $1.514 | CapitalGainLongTerm |
| Aug 27, 2007 | $0.169 | CapitalGainLongTerm |
| Dec 22, 2006 | $0.263 | OrdinaryDividend |
| Dec 22, 2006 | $0.187 | CapitalGainShortTerm |
| Dec 22, 2006 | $1.337 | CapitalGainLongTerm |
| Aug 28, 2006 | $0.031 | CapitalGainShortTerm |
| Aug 28, 2006 | $0.073 | CapitalGainLongTerm |
| Dec 28, 2005 | $0.009 | OrdinaryDividend |
| Dec 28, 2005 | $0.068 | CapitalGainShortTerm |
| Dec 28, 2005 | $1.266 | CapitalGainLongTerm |
| Aug 29, 2005 | $0.014 | CapitalGainShortTerm |
| Aug 29, 2005 | $0.248 | CapitalGainLongTerm |
| Dec 29, 2004 | $0.480 | CapitalGainShortTerm |
| Dec 29, 2004 | $0.367 | CapitalGainLongTerm |
| Aug 30, 2004 | $0.045 | CapitalGainShortTerm |
| Aug 30, 2004 | $0.140 | CapitalGainLongTerm |
| Dec 30, 2003 | $0.407 | CapitalGainShortTerm |
| Aug 27, 2002 | $0.041 | CapitalGainShortTerm |
| Aug 27, 2002 | $0.062 | CapitalGainLongTerm |
| Dec 26, 2001 | $0.003 | OrdinaryDividend |
| Dec 26, 2001 | $0.189 | CapitalGainShortTerm |
| Dec 26, 2001 | $0.126 | CapitalGainLongTerm |
MFVAX - Fund Manager Analysis
Managers
Donald Kilbride
Start Date
Tenure
Tenure Rank
Mar 28, 2017
5.18
5.2%
Donald J. Kilbride Senior Managing Director, Partner, and Equity Portfolio Manager Don is a portfolio manager in Global Equity Portfolio Management on the Quality Equity team. He manages equity assets on behalf of our clients, drawing on research from Wellington Management’s global industry analysts, equity portfolio managers, and team analysts. Don currently manages Wellington's Dividend Growth and related approaches focusing on large-cap, quality companies with a value orientation. Prior to joining Wellington Management in 2002, Don was a senior investment analyst and director of Non-Technology Research at Greenberg-Summit Partners; his coverage area included energy, basic materials, financial services, aerospace/defense, and transportation (2001 – 2002). He also worked for six years as the director of US Equity Research at The Boston Company (1996 – 2001). Don received his MBA from the University of North Carolina’s Kenan-Flagler Business School (1991) and his BA from the College of the Holy Cross (1986).
John Linehan
Start Date
Tenure
Tenure Rank
Mar 28, 2017
5.18
5.2%
John Linehan is the portfolio manager for the Equity Income Strategy and co-portfolio manager of the US Large-Cap Value Strategy for T. Rowe Price. In addition, he is the chief investment officer of Equity and a member of the firm's US Equity Steering, Equity Brokerage and Trading Control, and Counterparty Risk Committees. Mr. Linehan is Chairman of the Investment Advisory Committee at T. Rowe. He is a large-cap value portfolio manager in the U.S. Equity Division and also co-chair of the Investment Advisory Committee for the Institutional Large-Cap Value Strategy. From February 2010 to June 2014, Mr. Linehan was head of U.S. Equity and chairman of the U.S. Equity Steering Committee. He is a member of the firm's U.S. Equity Steering, Equity Brokerage and Trading Control, and Counterparty Risk Committees. He earned a B.A. from Amherst College and an M.B.A. from Stanford University, where he was the Henry Ford II Scholar, an Arjay Miller Scholar, and the winner of the Alexander A. Robichek Award in finance. Mr. Linehan is a CFA® charterholder.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.04 | 39.02 | 7.27 | 2.42 |
